Burcon announces change to investor relations program in Europe



    VANCOUVER, Aug. 2 /CNW/ - Burcon NutraScience Corporation (TSX-V: BU)
announces today the resignation of Mr. Roderick Adams of London, United
Kingdom. Mr. Adams was engaged in October 2006 to assist Burcon with its
existing investor relations program in Europe. The initial term of the
investor relations agreement (the "Agreement") between Burcon and Mr. Adams
was for 8 months but extendable for another 12 months unless either party gave
written notice to the other party to renegotiate or terminate the Agreement no
less than 30 days prior to the renewal term. The Agreement was also terminable
upon 30 days notice by either party. Due to his other professional
commitments, Mr. Adams decided, on July 3, 2007, to provide Burcon with notice
of termination of the Agreement. Over the last 10 months, Mr. Adams has
assisted Burcon with its investor relations activities and communication
strategies in Europe.
    Since 2003, Burcon has been working with Axino AG in Germany to assist
Burcon in developing its investor relations program in Europe. Going forward,
Burcon intends to work exclusively with Axino to further investor awareness in
Europe. Burcon believes that working with a single investor relations
consultant can cost-effectively provide investors in that region with a
central point of contact for investor communications.
    "We appreciate and thank Mr. Adams for his contributions to Burcon's
investor relations program."
    For more information about Burcon view our new website at www.burcon.ca

    About Burcon NutraScience

    Burcon is a research and development company developing a portfolio of
composition, application, and process patents around its plant protein
extraction and purification technology. The goal of Burcon's research is to
develop its patented process to utilize inexpensive oilseed meals for the
production of purified plant proteins that exhibit valuable nutritional,
functional or nutraceutical profiles. Burcon, in conjunction with Archer
Daniels Midland, is currently focusing its efforts on developing the world's
first commercial canola proteins, Puratein(R) and Supertein(TM). Canola,
recognized for its nutritional qualities, is the second-largest oilseed crop
in the world after soybeans. Burcon's goal is to develop Puratein(R) and
Supertein(TM) to participate with soy, dairy, and egg proteins in the
expanding multi-billion-dollar protein ingredient market, with potential uses
in prepared foods, nutritional supplements, and personal care products.

    ON BEHALF OF THE BOARD OF DIRECTORS
    "Johann F. Tergesen"
    Johann F. Tergesen
    President & Chief Operating Officer

    The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy of the content of the information contained
herein. This press release contains forward-looking statements that involve
risks and uncertainties. These forward-looking statements relate to, among
other things, plans and timing for the introduction or enhancement of our
products, statements about future market conditions, supply and demand
conditions, and other expectations, intentions and plans contained in this
press release that are not historical fact. Our expectations regarding the
prospect for future success depend upon our ability to develop and sell
products, which we do not produce today and cannot be sold without further
research and development. When used in this press release, the words "goal,"
"intend," "believes" and "potential" and similar expressions, generally
identify forward-looking statements. These statements reflect our current
expectations. They are subject to a number of risks and uncertainties. In
light of the many risks and uncertainties surrounding the development of a
source of protein from canola meal, you should understand that we cannot
assure you that the forward looking-statements contained in this press release
will be realized.





For further information:

For further information: Jade Cheng, Chief Financial Officer, Burcon
NutraScience Corporation, (604) 733-0896, (888) 408-7960 toll-free,
jcheng@burcon.ca, www.burcon.ca; AXINO AG, Sven Olsson, Investor Relations
Europe, Silberburgstrasse 112, D-70176 Stuttgart, Germany, Tel. +49-711-25 35
92-30, Fax +49-711-25 35 92-33, olsson@axino.de, www.burcon.net

Organization Profile

Burcon NutraScience Corporation

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890